Bergera J. Joseph 4
4 · ITERIS, INC. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
ITERIS, INC.ITI
Bergera J. Joseph
President and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-02-29$2.38/sh+14,000$33,320→ 193,138 total - Sale
Common Stock
2024-02-29$5.19/sh−10,714$55,564→ 182,424 total - Exercise/Conversion
Common Stock
2024-03-01$2.38/sh+18,500$44,030→ 200,924 total - Sale
Common Stock
2024-03-01$5.17/sh−12,736$65,897→ 188,188 total - Exercise/Conversion
Common Stock
2024-03-04$2.38/sh+4,323$10,289→ 196,561 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-01$2.38/sh−18,500$44,030→ 1,117,500 totalExercise: $2.38Exp: 2025-09-22→ Common Stock (18,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-04$2.38/sh−17,500$41,650→ 1,100,000 totalExercise: $2.38Exp: 2025-09-22→ Common Stock (17,500 underlying) - Exercise/Conversion
Common Stock
2024-03-04$2.38/sh+17,500$41,650→ 205,688 total - Sale
Common Stock
2024-03-04$5.03/sh−13,450$67,633→ 192,238 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-29$2.38/sh−14,000$33,320→ 1,136,000 totalExercise: $2.38Exp: 2025-09-22→ Common Stock (14,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-04$2.38/sh−4,323$10,289→ 1,095,677 totalExercise: $2.38Exp: 2025-09-22→ Common Stock (4,323 underlying)
Footnotes (5)
- [F1]As disclosed in Iteris' Form 10-Q for the quarter ended December 31, 2023, pursuant to a Rule 10b5-1 plan adopted on November 30, 2023, the Reporting Person sold only enough shares to cover the exercise price and related taxes upon the Reporting Person's exercise of a portion of his stock options that expire in September 2025. The Reporting Person retained all of the remaining shares purchased upon exercise.
- [F2]The reported securities were sold in multiple transactions at prices ranging from $5.11 to $5.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The reported securities were sold in multiple transactions at prices ranging from $5.06 to $5.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The reported securities were sold in multiple transactions at prices ranging from $5.00 to $5.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]The option vested in full on September 22, 2019.